Experimental drug tested for Tough-to-Treat blood cancers
NCT ID NCT00875056
Summary
This study tested the safety and effectiveness of the drug vorinostat in people whose follicular lymphoma or similar slow-growing B-cell lymphomas had returned or stopped responding to previous treatments. It involved 56 participants who had tried up to four prior chemotherapy regimens. The main goal was to see how many patients' cancers responded to the new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.